Navigation Links
Hepatitis in Medical News

Surveyed Physicians Will Treat Over 50 Percent of Hepatitis C Genotype 1-Infected Patients With the Protease Inhibitor Telaprevir

WALTHAM, Mass., Aug. 4 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, based on profiles provided to them of emerging protease inhibitors, surveyed physicians indicate that they will prescr...

Top Hepatitis C Treatments Equally Effective

Landmark assessment also finds treating early helps prevent liver failure WEDNESDAY, July 22 (HealthDay News) -- A landmark hepatitis C virus study shows that the top two treatment options are equally effective and safe. The long-awaited study, thought to be the largest of its kind...

Mass. General-based research center will investigate why immune system fails to control hepatitis C

A research consortium based at Massachusetts General Hospital (MGH) has been awarded $15 million from the National Institute of Allergy and Infectious Diseases to investigate how the hepatitis C virus (HCV) resists suppression and clearance by the immune system. The five-year grant will support a...

New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report

NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue. World Hepatitis C Virus And Therapeutics Market http://www.reportlinker.com/p0119497/World-Hepatitis-C-Virus-And-Therapeutics-Market.html?utm_source=PRNWire&utm_medium=...

Pharmasset Nominates PSI-938 as a New Nucleotide Analog Inhibitor of Hepatitis C for Preclinical Development

PRINCETON, N.J., July 7 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS ) announced today the nomination of PSI-352938 ("PSI-938") as a lead development candidate from two series of purine analogs for the treatment of chronic hepatitis C virus (HCV) infection. PSI-938 is a proprietary n...

JNCI news brief: Hepatitis B virus mutations may predict risk of liver cancer

Certain mutations in the DNA of the hepatitis B virus (HBV) are associated with the development of liver cancer and may help predict which patients with HBV infections are at increased risk of the disease, according to a large meta-analysis in the Journal of the National Cancer Institute , publis...

More>>

Hepatitis in Medical Technology

Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C

PRINCETON, N.J., July 31 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS ) reported today positive preliminary results from its phase I clinical trial of PSI-7851 for the treatment of hepatitis C (HCV). PSI-7851 is a second generation nucleotide polymerase inhib...

Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)

CAMBRIDGE, Mass., July 20 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it has successfully completed a three-day...

Clinical Update - Debio 025 in Hepatitis C

LAUSANNE, Switzerland, April 28 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions, particularly in the field of oncology, presented results from a phase IIa study with Debio 025, a selective cyclophilin (...

Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting

Final results from three large PEGINTRON(TM) clinical studies address key questions in the treatment of hepatitis C COPENHAGEN, Denmark, April 27 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) today reported that final results of three large PEGINTRON(TM) (peginterferon ...

Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen

- Combination of R7227, protease inhibitor, and R7128, nucleoside polymerase inhibitor, shows significant potency in reducing viral load in patients with hepatitis C - NUTLEY, N.J., BRISBANE, Calif., and PRINCETON, N.J., April 25 /PRNewswire-FirstCall/ -- Roche, InterMune, Inc. (Nasdaq: IT...

Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C

- With half as many injections, in two pivotal Phase 3 trials, Albuferon (albinterferon alfa-2b) met the primary efficacy endpoint of sustained virologic response comparable to Pegasys (peginterferon alfa-2a) - - Patients receiving 900-mcg Albuferon had comparable rates of serious and...

More>>

Hepatitis in Medical Products

Hepatitis C Virus Quantitative with Reflex to Hepatitis C Genotype

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Company:ARUP Laboratories

Autoimmune Hepatitis Panelwith Reflex to ANA IFA Titer

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Company:ARUP Laboratories

Autoimmune Hepatitis Panel Pluswith Reflex to Titers

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Company:ARUP Laboratories

NOW® Hepatitis B Test

Description: The NOW Hepatitis B test is a rapid field or laboratory test for the differential diagnosis of a Hepatitis B infection. This simple, two-step test provides results in 10 minutes, allowing for accurate treatment and improved patient outcomes. Intended use: The NOW® Hepatitis B sAg/eAg tes...
Company:Binax, Inc.

Determine HBsAg - Whole blood (includes chase buffer)

Description:... For the qualitative detection of hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
Company:Inverness Medical Professional Diagnostics

Determine HBsAg - Serum & Blood

Description:... For the qualitative detection of hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
Company:Inverness Medical Professional Diagnostics

More>>

Hepatitis in Medical Definition

Pathology

...s Hernia Inguinal - Femoral - Umbilical - Incisional - Diaphragmatic Liver Alcoholic liver disease - Cholestasis - hepatitis - Liver failure - Cirrhosis - NASH - PBC - Budd-Chiari - Hepatocellular carcinoma Accessory digestive Gallbladder / Biliary tree...

Réseau Sentinelles

... since 2004, Male urethritis since 1984 and hepatitis A Virus ( HAV ), hepatitis B Virus ( HBV ) and hepatitis C Virus ( HCV ) since 2000 as well as 3 non ...

Unsolved problems in medicine

...ndamental cure for all cancers? HIV / AIDS . Can we develop a vaccine or cure that wipes out all strains of HIV? Where did HIV originate? hepatitis / Herpes . And other incurable pathogenic diseases and conditions. We can treat them but how can we eliminate them? Hereditary diseases . Can gene...
Hepatitis in Medical Dictionary

Hepatitis

Comprehensive collection of resources on the five hepatitis viruses (A, B, C, D, and E) that cause liver disease. ... of fact sheets for the public and the health professionals about hepatitis A which affects the liver, occurring in situations ranging from isolated cases ... Features ...

Viral hepatitis

Viral hepatitis is liver inflammation due to a viral infection. It may present in acute or chronic forms. The most common causes of viral hepatitis are the five unrelated hepatotropic viruses Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D, and Hepatitis E. In... ...

Drug-induced hepatitis

3.3 Alcoholic hepatitis . 3.4 Drug induced . 3.5 Other toxins. 3.6 Metabolic disorders ... of drug - induced hepatitis is quite variable, depending on the drug and the ... Definition: Drug - induced hepatitis involves inflammation of the liver caused by medicati...

Autoimmune hepatitis

Anomalous presentation of human leukocyte antigen (HLA) class II on the surface of hepatocytes, possibly due to genetic predisposition or acute liver infection; causes a cell-mediated immune response against the body's own liver, resulting in autoimmune hepatitis . Although auto...

Viral Infections

...nto wounds and cause an infection . Get the details in this article for teens. ... Infections >Bacterial & Viral Infections > ... hepatitis is most commonly caused by one of three viruses. ... KidsHealth>Parents> Infections >Bacterial & Viral Infections >Hepatitis. Prin...

Viral

...h flu. From the U.S. ... Home Page of Viral hepatitis ... Adult Viral hepatitis Prevention Coordinators. Perinatal hepatitis B Prevention Coordinators ... Overview of hepa...

More>>

Hepatitis in Biological News

The hepatitis healing power of blueberry leaves

A chemical found in blueberry leaves has shown a strong effect in blocking the replication of the Hepatitis C virus, opening up a new avenue for treating chronic HCV infections, which affect 200 million people worldwide and can eventually lead to cirrhosis and liver cancer. Among the areas of ...

First human gets new antibody aimed at hepatitis C virus

Boston, Mass. Building upon a series of successful preclinical studies, researchers at MassBiologics of the University of Massachusetts Medical School (UMMS) today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody they developed ...

Novel antibody prevents infection by hepatitis C virus

Boston, Mass. Taking aim at a leading cause of liver failure in the United States, a team of scientists at the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) has developed a human monoclonal antibody that neutralizes the Hepatitis C virus (HCV...

Biolex presents Locteron US Phase 2a hepatitis C data at EASL

Biolex Therapeutics, Inc. announced that the results from its United States Phase 2a clinical trial (the "PLUS" trial) of Locteron will be presented today at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL) in Copenhagen, Denmark. Locteron, controlled-release i...

When acute hepatitis develops into chronic hepatitis

To achieve this, Carlos A. Guzmn, Head of the "Vaccinology and Applied Microbiology" working group and Robert Geffers, Head of the "Gene Expression Analysis" platform, examined the incidence and species of special defence cells, T helper cells, along with their role in the development of the disea...

Discovery could lead to a new animal model for hepatitis C

During its career, the potentially fatal hepatitis C virus has banked its success on a rather unusual strategy: its limitations. Its inability to infect animals other than humans and chimpanzees has severely hampered scientists in developing a useful small animal model for the disease. But now, in...

More>>

Hepatitis in Biological Technology

Eiger BioPharmaceuticals Acquires Exclusive License to Novel Hepatitis C Virus (HCV) Technology From Stanford University

PALO ALTO, Calif., August 4, 2009 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that it has licensed the exclusive worldwide rights to novel Hepatitis C Virus (HCV) technology from Stanford University. This te...

Three Rivers Announces Positive Results from Phase 3 DIRECT Trial of Once-Daily INFERGEN(R) with Ribavirin in Hepatitis C Virus Treatment Failures

WARRENDALE, Pa., June 16 /PRNewswire/ -- Three Rivers Pharmaceuticals announced today positive results of the U.S.-based, randomized Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy (DIRECT) clinical trial authored by Bruce R. Bacon, M.D., of Saint Louis University , an...

Study Finds Noninvasive Blood Test for Liver Fibrosis May Alleviate Need for Liver Biopsies for Some Patients with Chronic Hepatitis C

MADISON, N.J., June 8 /PRNewswire-FirstCall/ -- A study in the June issue of Clinical Gastroenterology and Hepatology , published by Elsevier, demonstrates that the Hepascore(TM) liver fibrosis blood-serum test panel may help physicians more accurately diagnose and stage liver fibrosis in patie...

Idenix Pharmaceuticals Reports Data From Three Hepatitis C Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver

CAMBRIDGE, Mass., April 23 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today reported data from its three hepatitis C development programs being pr...

Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference

CAMBRIDGE, Mass., April 3 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ) announced today that management will present an overview of the company's three hepatitis C programs at the Canaccord Adams Hepatitis C Conference on Tuesday, April 7 at 9:45 a.m. ET at the InterCont...

InterMune to Present at Canaccord Adams Hepatitis C Conference

BRISBANE, Calif., April 3 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that Steven B. Porter, M.D., Ph.D., Chief Medical Officer of InterMune, will present at the Canaccord Adams Hepatitis C Conference on April 7, 2009 at 11:15 a.m. EDT. To access a live audio...
Hepatitis in Biological Products

ELISA Kit for Hepatitis B Surface Antigen Using GoldMag-AS Microparticles from BioChain

Description: The ELISA Kit for Hepatitis B Surface Antigen (HBsAg) is an in vitro enzyme immunoassay for the detection of HBsAg in human serum or plasma....
Company:BioChain

Normal Pooled Human Serum from Innovative Research

Description:...n (s) (HIV-1Ag), Antibodies to Human Immunodeficiency Virus (Anti-HIV 1/2), hepatitis C Virus (HCV), and Nonreactive for hepatitis B Surface Antigen (HbsAg) and Non-reactive by a screening test for syphilis...
Company:Innovative Research

Normal Human Serum-Single Donor from Innovative Research

Description:...n (s) (HIV-1Ag), Antibodies to Human Immunodeficiency Virus (Anti-HIV 1/2), hepatitis C Virus (HCV), and Nonreactive for hepatitis B Surface Antigen (HbsAg) and Non-reactive by a screening test for syphilis...
Company:Innovative Research
Hepatitis in Biological Definition

Blood

...nfection. AIDS , the virus of which, HIV , is transmitted through contact between blood, semen , or the bodily secretions of an infected person. hepatitis B and C are transmitted primarily through blood contact. Owing to blood-borne infections, bloodstained objects are treated as a biohazard . Inf...

Flaviviridae

...wing genera: Genus Flavivirus (type species Yellow fever virus , others include West Nile virus ) Genus Hepacivirus (type species hepatitis C virus ) Genus Pestivirus (type species Bovine viral diarrhea virus , others include classical swine fever or hog cholera) The genome ...

Hepadnaviridae

...e two genera included here: Genus Orthohepadnavirus ; type species: hepatitis B virus Genus Avihepadnavirus ; type species: Duck hepatitis B virus Hepadnaviruses have very small genomes of circular, partia...

Hepatitis B

... Originally known as serum hepatitis, hepatitis B has only been recognized as such since World W...rrent epidemics in parts of Asia and Africa . hepatitis B is recognized as endemic in China and various ...d's population has been or is actively infected by hepatitis B. ...

Liver

...from the blood and excretes it through bile. hepatitis , inflammation of the liver, caused mainly by vari...r diseases leading to cirrhosis , such as chronic hepatitis C, alcoholism, autoimmune hepatitis, and many othe... Melissa Palmer. Dr. Melissa Palmer's Guide to hepatitis and Liver Disease: What You Need to Know , Avery ...

RNA virus

...terial passes through an RNA intermediate during replication. For example, hepatitis B virus is classified as an RNA virus, even though its genome is double-st...es: Arenaviridae Bunyaviridae Flaviviridae : Yellow fever - hepatitis C&G Orthomyxoviridae : Influenza Paramyxoviridae : Mumps ...
Hepatitis in Biological Dictionary

Untranslated region

... terminal 3' stem-loop domain. Control of translation by ... ... of the 5' Untranslated Region Cannot Accurately Distinguish Genotypes ... of hepatitis C Virus with Reference to C/E1 and 5' Untranslated Region Sequences. ... ... loop in the coronavirus 5' untranslated region plays a functio...

Thymus gland

...ymus gland phlegm stagnation is a primary causative factor for allergies. ... NatCell Thymus and thymus gland extracts use in treatment of hepatitis C. ... Much of the healthy thymus gland structure typically atrophies by age 20, and ... In humans, the thymus is a soft, flattened, pinkish-...

Satellite RNA

...BBSV satellite RNA . ... Barley yellow dwarf virus satellite RNA : Helper - Luteovirus ... It is like a satellite RNA since it requires hepatitis virus for transmission ... The satellite RNA of bamboo mosaic virus (satBaMV) has a single open reading ... Translation of the satellite ...

RNA virus

...sh ... RNA (redirected from RNA viruses ) Also found in: Medical, Encyclopedia, Wikipedia, Hutchinson ... ... viruses , which include HIV and hepatitis B, copy their RNA into ... Double-stranded RNA viruses -- which include the rotavirus that kills about one ... RNA viruses : constant anno...

Replicon

...oftware used in productivity and expense management applications. Its... hepatitis C Virus Rna Replicon Model: Soon after the discovery of the hepatitis C virus, attention turned to the development of models whereby replication...

Recombinant

... of recombinant biotechnology. ... Recombinant Human Insulin. Diabetes. hepatitis B Vaccine. hepatitis B ... The RWJMS Recombinant DNA form should be completed and submitted...
Other Tags
(Date:7/12/2014)... injuries increase in the summer as people gather around fire ... most vulnerable to these seasonal fire hazards: children. "Young ... by putting their hands on the side of cooking grills," ... Loyola University Medical Center in Maywood, Ill., said in a ... play with fire, you get burned, is true -- ...
(Date:7/12/2014)... “After my mom’s stroke, she loss the use of her ... use of his left side. Eating became a difficult task for ... like them enjoy eating again,” said an inventor, from Fayetteville, N.C. ... HALL PLATE (P C H PLATE). , The PATRICIA CAROL HALL ... eat for individuals who suffer from stroke, experience tremors or loss ...
(Date:7/12/2014)... With prom shopping reaching its final ... is ready to showcase its new and trendy apparels. ... evening dresses in its online shop. Additionally, it is ... these elegant gowns. According to the company’s sales manager, ... 26, 2014. , He says, “Now, worldwide clients ...
(Date:7/12/2014)... “Critical Care Therapeutics in Major Developed ... PCCs and Recombinant Products to Drive Market,” which ... in the US, UK, France, Germany, Italy, Spain, ... of market size for 2013, along with market ... that are being treated using the five major ...
(Date:7/12/2014)... Utah Valley Entrepreneurial Forum Top 25 ... being bestowed to companies in revenue, and pre-revenue startups. ... with recognition for new ideas as well as companies ... , 25 Under 5 highlights outstanding Utah entrepreneurs and ... 5 years old. Award recipients were recognized at their ...
Breaking Medicine News(10 mins):Health News:Burn Injuries More Common in Summer 2Health News:VogueQueen.com Updates Its Summer Collection With New And Trendy Evening Dresses 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 3Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 4Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 5Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 6Health News:SquareHook is Recognized for UVEF 25 Businesses Under 5 Years-Watch Out 2
(Date:7/10/2014)... NEW YORK , June 27, 2014 /PRNewswire/ ... against Provectus Biopharmaceuticals, Inc. ("Provectus" or the "Company")(NYSE-MKT: ... action, filed in United States District Court, Middle ... Division, is on behalf of a class consisting ... otherwise acquired Provectus securities between December 17, 2013 ...
(Date:7/10/2014)... SPRINGS, Florida , July 1, 2014 ... wallets pave way for convenience and improved security: NXT-ID, Inc. ... Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: ... and MasterCard Corporation (NYSE: MA) NXT-ID, Inc., (OTCQB: NXTD) ... is pleased to announce that the second series of 30 ...
(Date:7/10/2014)... July 2, 2014 It is a great ... the appointment of the world-renowned Thoracic and Cardiovascular surgeon, ... Dr. Ginsburg, with over 34 years of ... Hospital and Good Samaritan Regional Medical Center. Dr. Ginsburg ... late 1980,s and is considered an expert in the ...
Breaking Biology News(10 mins):SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 2Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 4Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 5Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2
Other Contents